Pfizer, University College London enter pact to develop stem cell-based therapies
Pfizer Regenerative Medicine announced that it has entered into a collaboration and license agreement with University College London (UCL) focused on gaining better understanding into how to develop stem cell-based therapies for certain ophthalmic conditions.
[Read the full article here]Related News:
Pfizer And University College London Announce Collaboration To Advance Development Of Stem Cell-Based Therapies
GICD, Stanford University collaborate to develop stem cell and regenerative medicine therapies
Pfizer Regenerative Medicine to work wth Athersys on stem cell therapies